ATRA treatment alone downregulated the expression levels of CD86 and F4/80 and slightly increased the level of CD11c on MDSCs compared to those in the tumor-bearing control group, which indicated that ATRA treatment alone could not regulate the phenotypic maturation of MDSCs (Figures 3C, D). The gene discussed is ITGAX; the disease is neoplasm.